{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-074974","form_type":"8-K","ticker":"RBOT","cik":"0001812173","company_name":"Vicarious Surgical Inc.","filed_at":"2025-08-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.077059+00:00","generated_at":"2026-05-17T14:47:47.366321+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Vicarious Surgical Q2 net loss narrows to $13.2M; CEO transition to Stephen From","bullets":["GAAP net loss of $13.2M ($2.23/share) vs. $15.2M ($2.59/share) in Q2 2024.","Operating expenses fell 24% YoY to $13.5M; R&D $9.1M, G&A $4.1M, S&M $0.3M.","Cash and investments $24.0M; Q2 cash burn $13.4M; FY2025 cash burn guidance ~$50M.","Adam Sachs becomes President; Stephen From appointed CEO effective August 12, 2025.","Non-GAAP adjusted net loss $13.3M ($2.23/share) vs. $16.8M ($2.86/share) year ago."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-074974","json":"https://secwatch.observer/filing/0001213900-25-074974.json","markdown":"https://secwatch.observer/filing/0001213900-25-074974.md","text":"https://secwatch.observer/filing/0001213900-25-074974.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1812173/000121390025074974/0001213900-25-074974-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1812173/000121390025074974/ea0252727-8k_vicarious.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T14:47:47.366321+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}